1. A method has been developed for the iodination of ox growth hormone by using iodine monochloride, giving a product which is 93 + 4% bindable to antiserum. 2. The 131Ior 125I-labelled growth hormone obtained has been used in the development of an immunological assay for growth hormone. 3. The assay could be applied to the measurement of growth-hormone output by pituitary slices in vitro. 4. On incubation ox-pituitary slices liberate 8-1% of their growth-hormone content in the first hour and 4-5% in the second hour. 5. The amount of growth
1. A method has been developed for the iodination of ox growth hormone by using iodine monochloride, giving a product which is 93 + 4% bindable to antiserum. 2. The 131Ior 125I-labelled growth hormone obtained has been used in the development of an immunological assay for growth hormone. 3. The assay could be applied to the measurement of growth-hormone output by pituitary slices in vitro. 4. On incubation ox-pituitary slices liberate 8-1% of their growth-hormone content in the first hour and 4-5% in the second hour. 5. The amount of growth hormone liberated into the medium is greater if the tissue is frequently transferred than if it is incubated in the same medium. 6. The output is stimulated by a hypothalamic extract but inhibited by high concentrations of posterior-lobe powder: a stalk-median-eminence extract had no effect. 7. The output is lowered by temperature reduction, ,-hydroxybutyrate, acetoacetate, and pyrivate, glutamate and fumarate. Palmitoylcamitine stimulates growth-hormone output. 8. Anoxia and 2,4-dinitrophenol have no effect on output.
Several studies on the secretion of growth hormone by isolated pituitary preparation have used the tibia test for the measurement of growthhormone release (Franz, Hasselbach & Libert, 1962; Schally, Steelman & Bowers, 1965; Deuben & Meites, 1964) . However, bioassay may not be the most suitable procedure for these determinations since it may be influenced by other pituitary hormones, e.g. corticotrophin (Becks, Simpson, Marx, Li & Evans, 1944) , thyrotrophin (Geschwind & Li, 1952) and gonadotrophins (Simpson, Marx, Becks & Evans, 1944) . The purpose of the present study was to develop a more specific and simple assay method and to use it for studies on the release of growth hormone by pituitary tissue in vitro. Ox-pituitary slices were used because of the availability of ox growth hormone in sufficient quantities to produce the antisera required for the assay method; slices of ox pituitary have also been used to study the release of thyrotrophin in vitro (LaBella, 1964) . The method chosen for the measurement of growth hormone was based on the insulin assay described by Hales & Randle (1963) . Solutions of growth hormone at known or unknown concentrations are incubated with a guinea-pig antiserum to ox growth hormone. 131I-or 1251-labelled ox growth hormone is added to react with any free antiserum remaining in solution, and the antiserum precipitated with a rabbit antiserum to guinea-pig y-globulin. The precipitate is recovered by filtration on cellulose acetate membranes and the radio-activity in the precipitate, which is inversely related to the concentration of unlabelled growth hormone, is determined.
With this method it has been shown that growthhormone release by ox-pituitary slices in vitro may provide a useful model for the study ofthe control of growth hormone release in vivo, and evidence that the rate of release may be influenced by factors other than the hypothalamic releasing factor is presented.
MATERIALS AND METHODS
Chemicats. Bovine plasma albumin (fraction V) was obtained from the Armour Pharmaceutical Co. Ltd.
(Eastbourne, Sussex). Iodine monochloride was prepared by the method of McFarlane (1963) , giving a stock solution which was stored for up to 2 years at 4°. [ (Redhill Works, Hatfield, Herts.) : the anterior lobes were dissected and growth hormone was extracted by the procedure described by Dellacha & Sonnenberg (1964) . The freeze-dried powder was stored at -100.
Standard solutions of ox growth hormone. A stock solution was prepared by dissolving approx. 1mg. of ox growth hormone (accurately weighed) in 2OmN-NaOH and making up to 10ml. with phosphate buffer (40mm-sodium phosphate buffer, pH 7-4, containing 1mg. of albumin/ml. and 0.25mg. of merthiolate/ml.). The stock solution was stored at 40 for up to 5 days. Standard solutions were prepared by diluting the stock solution with phosphate buffer; doubling dilutions from 400 to 12.5m,ug./ml. were employed, each dilution being assayed in quadruplicate.
Preparation of 131Ior 125I-labelled ox growth hormone. pH8.5 was chosen for iodination of growth hormone with IC by the method ofMcFarlane (1963) because the hormone is readily dissolved at this pH. Iodine monochloride is reported to be stable at pH values below pH9 (Sidgwick, 1960) . Free radioactive iodine was separated from the labelled hormone as described by Greenwood, Hunter & Glover (1963) .
The stock IC1 solution (0-1 ml.) was diluted with 4-6ml. of m-NaCl, and 20p,. of N-NaOH added. A sample of this solution (lml.) was further diluted with 3ml. of borate buffer (6.1g. of H3BO3/l., 14-6g. of NaCl/l., adjusted to pH 1-6 with 2N-HCl). The dilute IC1 solution (40/l.) was added to 100,l. of 131I or 125I solution. Ox growth hormone (20,u1. of 100,ug. in 5mN-NaOH) was then added and after 5min. the reaction was stopped by addition of 20,ul. of 28mM-Na2S203 and 500,ul. of 133mM-NaI. The products were transferred to a column (9in. x lin.) of Sephadex G-25 equilibrated with borate buffer containing albumin to prevent adsorption of growth hormone (1-2g. of HoBO3/1I., 2-9g. of NaCl/l., 2g. of albumin/I., 0-25g. of merthiolate/l., adjusted to pH9-0 with 0-2N-NaOH). The labelled growth hormone was eluted with this buffer and stored at -100 as 0-5ml. samples (because repeated freezing and thawing decreased reaction with antibody). It was estimated that 40% of the radioactivity was eluted in the growth-hormone fraction and that specific activities ranged from 24 to 140mc/mg. (mean 84mc/mg.), assuming no loss of growth hormone on the column. Trichloroacetic acid at final concentration 5% (w/v) precipitated 98-5% of the radioactivity and with excess of guinea-pig anti-(ox growth hormone) serum 95% of radioactivity was precipitated. The ability ofgrowth hormone to combine with antibody was thus retained after iodination. Starch-gel electrophoresis at pH 8-3 with the discontinuous buffer system described by Ferguson & Wallace (1961) showed that the labelled protein migrated slightly to the cathode as a single band and no radioactivity was associated with albumin ( Fig. 1 ).
Anti8era to ox growth hormone. Antisera to ox growth hormone were prepared in guinea pigs by four injections at monthly intervals of 1 mg. ofox growth hormone in complete Freund's adjuvant, followed by one injection of 1 mg. of ox growth hormone in 0-154M-NaCl. The animals were bled by cardiac puncture 1 week after the final injection and the antisera obtained were pooled and stored at -10°in 0-5ml. portions. Antisera to guinea-pig y-globulin. This antiserum was prepared in rabbits by the method described by Hales & Randle (1963) . labelled ox growth hormone (40m,uc in a solution containing lOp,g. of labelled hormone/ml. and 5mg. of albumin/ml.) were subjected to electrophoresis in the system described by Ferguson & Wallace (1961) . The gel was sliced and stained with nigrosin; strips of gel 1cm. wide and of 0-25cm. cross-section were weighed and counted in a Nuclear-Chicago liquid-scintillation spectrometer. The positions of the stained protein bands are shown beneath the concentration ofradioactivity in the gel.
Assay of ox growth hormone
Selection of concentration of anti8era. The amount of labelled ox growth hormone added in the assay was fixed at I mu,g. (in 50/,u.). The minimum concentration of anti-(ox growth hormone) serum capable of binding 50% of the labelled ox growth hormone, and the concentration of anti-(y-globulin) serum giving optimum precipitation of the anti-(ox growth hormone) serum were then determined. If the concentration of anti-(y-globulin) serum is too low, some anti-(ox growth hormone) serum remains unprecipitated, whereas if it is too high the amount of pre-, cipitation falls (see Table 1 ), probably owing to a prozone phenomenon (Kabat & Mayer, 1961) . The selection of antisera concentration was achieved by using a range of doubling dilutions of anti-(ox growth hormone) serum (from 1:150 to 1:4800 in phosphate buffer), and by using at each dilution a range of doubling dilutions of anti-(yglobulin) serum (1:2 to 1:32 in phosphate buffer). 131Ilabelled ox growth hormone (50,u.) was added to 50,u1. of anti-(y-globulin) serum; 50,ul. of anti-(ox growth hormone) serum was added and the whole incubated for 17hr. at 4°. The reaction mixture was filtered through cellulose acetate membranes as described by Hales & Randle (1963) . To lower the radioactivity adhering to the membrane in the absence of antiserum, labelled ox growth hormone was filtered through a cellulose acetate membrane immediately before use in an assay. With 131I, radioactivity was assayed in a Nuclear-Chicago gas-flow counter as described by Hales & Randle (1963) : when 125I was used, the membranes were placed in scintillation bottles, and, afterdryingat 1000, 5ml. of toluene containing 4g. of 2,5-diphenyloxazolell. and Table 1 . Effect of concentrations of antisera on the formnation of 131I-labelled ox growth hormone-antibody complex and it8 precipitation by anti-(yglobulin) serum A 20, u1. (Im, ug.) sample of 131I-labelled ox growth hormone solutionwasmixedwith 100 /A. of anti-(y-globulin) serum solution diluted in phosphate buffer containing albumin and merthiolate. A 20pLJ. sample of anti-(ox growth hormone) serum diluted in the same buffer was added, and the precipitate filtered after incubation for 17 hr. at 4°. Recoveries, expressed as percentage of the total 1311-labelled ox growth hormone added, were means of duplicate observations. 
Dilution
50mg. of 1,4-bis-(5-phenyloxazol-2-yl)benzene/l. was added and radioactivity assayed in a Nuclear-Chicago liquidscintillation spectrometer.
Assay of unknown 801ution8 of growth hormone. Portions (1001.) of incubation media containing ox growth hormone were diluted with 10ml. of phosphate buffer. Samples (100l1.) of the diluted media (in triplicate) or of standard growth-hormone solutions (in quadruplicate) were mixed with 501i. of an appropriate dilution of anti-(ox growth hormone) serum and incubated for 2hr. at 4°. Portions (50,1..) of a solution containing an appropriate dilution of anti-(y-globulin) serum and 1 mpg. of 131Ior 125I1-labelled ox growth hormone were added and, after mixing, incubated for 18hr. at 4°. The reaction mixture was then filtered through a cellulose acetate membrane, and the incubation tube washed with two ml. portions of phosphate buffer containing 5g. of albumin/l. The washings were filtered through the same membrane.
Incubation of ox-pituitary slice8
Pituitary slices. Pituitary glands were obtained from heifers at Bristol Corporation Public Abattoir, within 5min. of the death of the animal. The diaphragma sellae was dissected from the pituitary and the posterior lobe and stalk were removed. The anterior lobe was washed in incubation medium at 370 and sectioned horizontally by a Stadie-Riggs microtome. The thickness of the slices, estimated by weighing pieces of known area and assuming unit density, was approx. 0-3mm. Incubation medium. The medium for incubations was a bicarbonate-buffered salt solution (Krebs & Henseleit, 1932) containing bovine plasma albumin (2mg./ml.). The gas phase was 02+ CO2 (95:5). Further additions to the medium were as described in the text or in the Tables. Incubation of slice8. Eight complete slices were preincubated at 370 for 30min. in 20ml. of incubation medium containing 2mg. ofglucose/ml. during transfer to the laboratory. They were then divided along the mid-line so that one half was used as a control for the other, washed and transferred to 25 ml. conical flasks containing 2-5 ml. ofincubation medium, gassed, and incubated at 370 with shaking at 100cyc./min. The tissue was washed and transferred to fresh medium after either Ihr. or 1 hr. incubation.
Measurement of tissue growth-hormone content. A crude pituitary extract was prepared by homogenization of pituitary slices in ice-cold 0-154m-NaCl containing 5mN-NaOH; for assay the homogenate was diluted 1: 10000 with phosphate buffer without prior neutralization.
Calculation of results. The rates of release of growth hormone have been calculated and expressed in the Tables as milligrams of ox growth hormone/g. wet wt. of tissue/hr. Growth hormone is not uniformly distributed in the pituitary, being present mainly in the cortical regions (Schooley & Riddle, 1938) . Nevertheless, outputs based on the growth-hormone content of slices were more variable than those based on wet weight. The significance of differences in mean outputs in experimental and control flasks was assessed by calculating t values.
RESULTS

Standard curves for growth hormone
Reproducibility of standard curves. The mean of 29 standard curves from nine different batches of 131I-labelled ox growth hormone is shown in Table 2 . For purposes of comparison each standard curve is expressed in terms of the radioactivity recovered at a given concentration of unlabelled growth hormone, as a percentage of the radioactivity recovered in the absence of unlabelled growth hormone.
Because of the error in the zero point, however, the standard curves used for determination of growthhormone concentrations were expressed as counts/ min. on the membrane at increasing concentration of unlabelled growth hormone.
Sensitivity of the assay. From the analysis given by Brown, Bulbrook & Greenwood (1957) , an estimate (S) of the standard deviation is calculated from the formula:
where x is the mean of n determinations in one of N standard curves. For N = 10, S at zero ox growthhormone concentration was 7.7%, and at a concentration of 12-5mpg./ml. was 4.1%. The mimimum significant drop in radioactivity is given by: t S12 S2 n where t= 1-96 (P 0.05). For observations in quadruplicate the minimum significant drop in radioactivity was 8-6%, which would be caused by 380 ,u,ug. of ox growth hormone in 100,ul.
Validity ofassay when applied to incubation medium Heterogeneity of antiserum. Ox growth hormone prepared by the method of Dellacha & Sonnenberg (1964) , an ox-pituitary extract and the medium in which ox-pituitary slices had been incubated were subjected to electrophoresis in 1 % agar with veronal buffer, pH 8-6, I 0-05. On development against anti-(ox growth hormone) serum, two distinct precipitin bands were seen both in the ox growth hormone and in the ox-pituitary extract: these arcs had an identical electrophoretic mobility but a different curvature, diverging at each end. In the incubation medium, which contained less ox growth hormone, only one fainter band was seen. The apparent ox growth-hormone content of ox thyrotrophin was 1-35 + 0-46 % (w/w) (mean + s.E.M.), and that of ox prolactin 2-17 + 0.600/ (w/w). This may be due either to traces of an iodinated impurity and antibodies to it in the assay reagents, or to the presence of small concentrations of ox growth hormone in National Institutes of Health thyrotrophin and prolactin.
Destruction of 1311-labelled ox growth hormone. No destruction of growth hormone could be detected either during incubation or during assay. To test for destruction during assay, 131I-labelled ox growth hormone (12-5m,ug./ml.) was incubated in medium that had contained pituitary slices, diluted 1: 100, at 00 and 370 for 0, 2 and 6hr. After incubation the amount of damage was assessed by adding anti-(ox Table 3 . Effect of medium in which ox-pituitary slices had been incubated on the formation of 1311labelled ox growth hormone-antibody complex 13II-labelled ox growth hormone (10m,ug.) was added to medium in which pituitary slices had been incubated. The mixture was incubated at 00 or 370 for the times shown, and then l10t. of anti-(ox growth hormone) serum (undiluted) was added to 500,ul. of 131I-labelled ox growth hormone solution. Anti-(y-globulin) serum (100,lO., diluted 1:2) was added to lO1,I. of this mixture, and the precipitate filtered after 24hr. at 4°. The radioactivity recovered in the precipitate is given, expressed as a percentage of the total lhr.
2hr.
6hr. 00 85-3+ 1-2 83-4+ 1-6 86-1+ 1-5 37 85-3+ 1-2 87-8+ 1-2 82-7+ 1-4 growth hormone) serum, incubating at 40 for 1 hr., and then measuring the recovery of radioactivity in the precipitate after 24hr. incubation in anti-(yglobulin) serum. It was found (Table 3) that the recovery was not affected by the time or temperature of incubation in medium. Destruction during incubation of pituitary slices was assessed by incubating in the presence of 131I-labelled ox growth hormone and determining the proportion of radioactivity which was not precipitated by 7-5% perchloric acid after 30, 60, 90 and 120min. No diminution in the proportion of radioactivity precipitated by perchloric acid was observed after incubation of 131I-labelled ox growth hormone with pituitary tissue. Dilution of incubation medium. Serial dilutions of medium in which 1-55g. of pituitary tissue had been incubated were assayed in quadruplicate; the results and 95% confidence limits are shown in Fig. 2 . The apparent growth-hormone concentrations assayed in incubation media were independent of the dilution employed in the assay.
Comparison with bioassay. The concentration of growth hormone determined by immunoassay of incubation medium was compared with the concentration determined by bioassay, weight gain in 100g. hypophysectomized rats (Charles River Inc., North Willmington, Mass., U.S.A.) being used. Groups of three rats, whose weights were stable over the 2-weeks post-operative period, were injected once daily with 0-5ml. of 0-9% sodium chloride solution, solutions of ox growth hormone or incubation medium. The mean weight gains after 7 days are shown in Table 4 . From a log dose-response curve, an estimate for the concentration of ox growth hormone in undiluted medium of 216.g./ml. was obtained: this is within the range estimated by immunoasay of 179-269 ,ug./ml. (Fig. 2) .
Errors in the immunoa8say. The error arising in the assay technique was estimated by making quadruplicate determinations of unknown solutions and by reading from a standard curve (also obtained in quadruplicate) the concentration of ox growth hormone appropriate to each of the four determinations. The mean and standard deviation as a percentage of the mean were determined, and the results grouped according to the apparent growthhormone concentration (Table 5 ). It can be seen that the standard deviation was least in the range Table 4 . Bioassay of growth hormone in medium in which pituitary 8lice8 had been incubated Pituitary slices (total wt. 1.55g.) were incubated for 2hr.
in 20ml. of medium and the growth-hormone concentration in undiluted medium was determined by weight gain in hypophysectomized rats. Groups of three rats were injected once daily with 0-5ml. of incubation medium, standard ox growth hormone solutions, or saline (controls), and the mean weight gain was determined after 7 days. Each solution injected also contained 10,ug. of thyroxine/ml.
Group Saline
Ox growth hormone (150pg./ml.) Ox growth hormone (250,ug measured by immunoassay at different dilutions of incubation medium. Each point is the mean concentration+ S.D. for quadruplicate determinations. Pituitary slices (1-55g.) were incubated for lhr. in 20ml. of medium containing 2mg. of glucose/ml. and 2mg. of albumin/ml., and the medium was diluted in 40mM-phosphate buffer, pH7-4, containing albumin and merthiolate for assay. Conditions for the assay are given in Table 2 .
Mean weight gain (g.) ±s.X.M.
3-0+ 0-3 18.8+ 2.1 25-3+ 1-3 23-5+2-0 Table 5 . Precision of the immunoassay for growth hornone expressed as standard deviation8 of results from their observed means Incubation media containing growth hormone at unknown concentrations were assayed in quadruplicate and the mean and standard deviation as a percentage of the mean calculated for each solution. Standard deviations were combined for the observed concentration ranges shown; the number of solutions assayed is given in parentheses. 29-7+ 1.8 40-99m,ug./ml.: the incubation medium was therefore diluted to bring the concentration of ox growth hormone into this range for assay. The error arising in the dilution of unknowns and in the positioning of the standard curve (drawn as the best fit to seven points obtained in quadruplicate) was estimated by assaying again in triplicate 83 unknown solutions and calculating the standard deviation by the formula 8 = d2/2 N (Snedecor, 1952) , where N is the number of repeat observations and d is the difference between each pair. For N = 83, S was calculated to be + 18%. This standard Time of incubation (hr.) Fig. 3 . Growth-hormone output during incubation: effect of transfer to fresh medium. Ox-pituitary slices were incubated for 2hr. in 2-5ml. of medium containing 2mg. of albumin/mL. and 2mg. of glucose/ml. At 30min. intervals, either (0) a 01ml. sample of the incubation medium was removed for assay, or (o) the tissue slices were transferred to fresh medium. Each point represents the mean out-put+s.E.m. for 16 slices. deviation is greater than that calculated in Table 5 , presumably because each of the observations was separately diluted and assayed.
Range
Relea8e of growth hormone by pituitary 81wCe8 in vitro Output during the 2hr. incubation period. The output of growth hormone during two successive incubations each of 1 hr. and the tissue concentration after incubation are given in Table 6 . It can be seen that the output during the second hour is significantly less (P < 0.02) than that in the first hour: the percentages of growth-hormone release in the two incubation periods were 81 +0.6% (mean + s.E.M.) and 4*5 + 0.7% respectively. It was found that the fall in growth-hormone output over the period of incubation was more marked if the tissues were incubated throughout in the same medium than if they were transferred to fresh medium at 30min. intervals (Fig. 3) . This difference was still observed if 5mM-pyruvate, -glutamate and -fumarate were added to the medium. It was not due to inhibition by growth-hormone release during incubation (Table 7) , since addition of growth hormone to the medium had no effect on output. Pituitary slices were incubated in 2-5ml. of medium containing 2mg. of glucose/ml. and 2mg. of albumin/ml. Growth-hormone concentrations were measured after the first hour of incubation and mean rates of output (± s.E.M.) calculated for the two weight ranges shown; the number of observations is given in parentheses. The difference in the means was highly significant (P< 0.002). It appeared that the fall in output could be due to release of substances from the slice during incuba-tion, however. Thus the outputs, expressed in ,ug. of growth hormone/mg. wet wt./hr., were higher for smaller slices (Table 8) , and the presence of an anterior-pituitary powder in the medium to which 4o vfOthe tissues slices were transferred decreased the 0 output ofgrowth hormone into the medium (Fig. 4) . This inhibitory effect was not seen after dialysis of the anterior-pituitary powder against distilled -0 /water (four changes over 48hr.: Table 7) . was not altered by increasing -the albumin concentration from 2mg./ml. to 20mg./ml. and Slices were transferred to fresh medium to .6-Omg./ml. had no effect -on the rate of output at 30min. intervals. The concentration of anterior-pituitary (Table 9) , confirming the work of Schally' et al.
powder when added was 0.34mg./ml. and it contained 29mg. (1965) . Anoxia and 2,4-dinitrophenol (Table 9) of growth hormone/g. Other details were as given under were also without effect on the rate of growth- Fig. 3 . hormone release. Table 9 . Change in the rate of growth-hormone output in response to changeas in terMperatUre, glucose and albumin concentrations, and to anoxia and 2,4-dinitrophenol Experimental details are given in the text. Except where otherwise stated the incubation media contained 2mg. of glucose/ml. and 2mg. of albumin/ml. Slices were incubated for two 60min. periods except in the presence of N2+C02 (95:5), when 30min. periods were employed. Rates of output represent the mean+ S.E.M. for eight slices. .33 J. G. SCHOFIELD Output snr"pones to-. por-pitarY, stak-medianweminen0 and Ahypot&amisc e¢t8.;-The posterior-pituitary hormones pitressin (4,x 10-6 i.u./ ml.) and oxytocin (10-2 i.u./ml.) had,no effect on the output of growth hormone by pituitary slices:
Conditions
addition of a posterior-pituitary extract inhibited growth-hormone output (Table 1 .0). In the presence of the extract, output of growth hormone stopped after 30min.; however, if after I hr. incubation the tissue was transferred to fresh incubation medium containing the extract growth-hormone output wasresumed but ceased again after 30min. (Fig. 6 ). An extract prepared from ox stalk-median-eminence fragments had no effect on growth-hormone output (Table 10 ). This was surprising in view of the report by Schally et al. (1965) that pig and ox stalk-median-eminence extracts stimulated growth-hormone output by rat pituitaries in vitro. The,effect of a hypothalamic e;xtract on growthhormone output was tested in the presence and absence of 5mM-pyruvate, -glutamate and -fumarate. Stimulation was observed in both their presence and absence (Table 10 ).
Out5u in response to alternative respiratory substrates. Addition of pyruvate, glutamate. and. fumarate (15mm) or fi-hydroxybutyrate (5lmm) or acetoacetate (5mM) to the inoubation medium lowered the output of growth hormone (Table 1-1) .
Although pyruvate, glutamate and fumarate added together had a significant effect on growth-hormone output in both the first (P < 0-025) and second (P < 0.001) hours of incubation, acetoacetate had a significant effect (P < 0-025) in the first hour and the ,-hydroxybutyrate effect was significant (P < 0.01) in the second hour. Sodium butyrate (5mM), and sodium palmitate (1.3mM) carried by albui (20mg./ml.), had no significant effect on the output ofgrowth hormone by the pituitary slices (Table 11) . The stimulation by palmitoyl-DL-carnitine observed (Table 11 ) was attributed to a detergent effect and not its utilization as a respiratory substrate; at the concentration used it causes lysis of growthhormone secretory granules.
DISCUSSION
The present studies were prompted by the need to distinguish between those substances which may alter the rate of growth-hormone secretion by direct action on the pituitary and those which may act via the hypothalamus. To this end an immunological assay for ox growth hormone was developed, and applied to incubation of ox-pituitary slices in vitro.
The double-antibody procedure used for the amsay (Hales & Randle, 1963) has been reported to be subject to interference when used to measure plasma Table 10 . Change in the rate of growth-hormone output in response to posterior-pituitary hormones and to posterior-pituitary, stalk-mnedian-eminence and hypothalamic extracts All incubation media contained 2mg. of glucose/ml. and 2mg. of albumin/ml.; other additions were as stated.
In Expts. 1-3 slice were incubated for 6Omin. periods and in Expts. 4-6 for 30min. periods. The mean rate of output+ 5.z.iz. is given and the number of lices included in parentheses. In Expt. 4 the output observed in the presence ofthe hypothalamic extract was greater by 34-5+ 11-7% (18) than the control output (P< 0-01).
Growth-hormone output (mg./g. wet wt./hr.)
Expt. concentrations of insulin (Morgan, Sorensen & Lazarow, 1964) and of growth hormone (Utiger, Parker & Daughaday, 1962; Cerasi, Della Casa, Luft & Roovete, 1966) . The interference arises from the presence of complement and y-globulin in plasma and from the binding of labelled growth hormone to plasma proteins (Schofield, 1966) , and it seemed unlikely that there would be similar interference when the assay was applied to incubation media, especially in view of the dilution involved. The validity of the assay was confirmed by the following observations. On dilution of the incubation medium the growth-hormone concentration fell as expected. The results obtained by immunoassay agreed closely with that obtained by bioassay. No destruction of 131I-labelled growth hormone by ox-pituitary slices could be detected, and the identical outputs of growth hormone in the presence and absence of added growth hormone suggest that the added growth hormone was not destroyed during incubation.
The presence of two bands on immunoelectrophoresis of ox growth hormone perhaps calls for some comment; it does not necessarily indicate the presence of impurities in the growth hormone used. It may be explained in terms of the presence of forms of the antigen with different physicochemical properties as reported by Hayashida & Grunbaum (1962) ; or to different behaviour ofthe precipitate in regions of excess of antigen and antibody. The extent of cross-reaction with ox prolactin and ox Vol. 103 thyrotrophin was very small and this might also suggest that the two bands, which were of equal intensity, did not arise from these impurities. Moreover, the labelled growth hormone appeared to be homogeneous on starch-gel electrophoresis.
It is difficult to conclude with certainty that the behaviour of pituitary slices in vitro with respect to growth-hormone output reflects the pattern of events in vivo. The physiological significance of the observation that the rate ofgrowth-hormone output falls on continued incubation in the same medium and can be increased by transfer to fresh medium is not clear. Solomon & McKenzie (1966) measured the output of thyrotrophin by halved rat pituitaries and found that it stopped after 30min. incubation in vitro, which they attributed to inhibition by thyrotrophin released. Inhibition by growth hormone released was unlikely to have occurred in the present investigation and added growth hormone did not prevent the output of growth hormone by pituitary slices. The observation that the ability of anterior-pituitary powders to inhibit growth-hormone output is lost on dialysis further indicates that a large protein molecule is not involved.
The rate of growth-hormone output in vitro over the second hour of incubation was 4-5 + 0-7%/hr.
On the basis of a half-life for growth hormone of 20min. (Hunter & Greenwood, 1964) , anl extracellular fluid volume of 501., and a pituitary growth-hormone content of 30mg., it can be calculated that the steady-state concentration of growth hormone in extracellular fluid would be 16m,ug./ml. if the rate of output observed in vitro were obtained in vivo. This is approximately five times the concentration of growth hormone measured by radio-immunoelectrophoretic assay in human plasma (Hunter & Greenwood, 1964) . No measurements of the plasma concentration of growth hormone in oxen are available, and, in view of the stress involved in slaughter, the observed rate of output in vitro could be physiological. Ando, Guze & Gold (1964) have reported an output of 7% of pituitary corticotrophin per hour and Solomon & McKenzie (1966) have found an average of 10% of pituitary thyrotrophin is released per hour in vitro. The percentage growth-hormone release reported here is below these limits. Schally et al. (1965) report outputs of rat growth hormone ranging from 0-5 to 0-15,g./mg./hr. averaged over a 9hr. incubation, but in view of the fall in output during incubation discussed previously the average rate of output observed by these workers would be expected to be less than the short-term rate of release. The rate of growth-hormone output was increased by crude hypothalamic extracts but was not altered by pitressin, oxytocin or stalk-median-eminence extracts. This latter finding conflicts with that of Schally et al. (1965) , who observed two-to seven-fold stimulation by ox or pig stalk-median-eminence extracts. The difference might be due to the presence of posterior-pituitary tissue in the samples ofstalk-median-eminence used in the present study, since posterior-pituitary extracts inhibited growthhormone outputs. The depression of the rate of growth-hormone output by temperature reduction was greater than that expected if the process of output in vitro was simply due to diffusion, and suggests that the output may be dependent on enzymic processes within the cell. The effect of ketone bodies on growth-hormone output, which has not previously been reported, might have physiological implications for the control of growthhormone secretion. It is, however, possible that respiratory substrates other than glucose are needed to maintain the pituitary in a viable state in vitro.
